Ciphergen Stock Jumps 6.8 Percent on Positive Nasdaq Outcome | GenomeWeb

Ciphergen Stock Jumps 6.8 Percent on Positive Nasdaq Outcome

Aug 25, 2006

NEW YORK (GenomeWeb News) – Shares in Ciphergen Biosystems were up 6.76 percent, or $.09, at $1.42 in mid-afternoon trading after the company said its shares have regained compliance with the Nasdaq exchange.

As GenomeWeb News reported this morning, Ciphergen said the exchange has allowed it to move its shares to its Capital Market from the National Market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

More Reproducible

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

To Catch the Swap

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

Face of the Suspect

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

This Week in Cell

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.